ArticleCancers2023

Metronomic Temozolomide (mTMZ) and Bevacizumab-The Safe and Effective Frontier for Treating Metastatic Neuroendocrine Tumors (NETs): A Single-Center Experience.

Çağlar Ünal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.